Duration of prior psychotic illness and clozapine response: a retrospective observational study using electronic health records
Background: Clozapine is the gold-standard medication for treatment-resistant schizophrenia (TRS) yet its initiation is often delayed. Objective: To examine whether earlier initiation of clozapine in TRS is associated with lower Clinical Global Impression – Severity (CGI-S) scores at 2 years. Method...
Main Authors: | Rowena Jones, Rachel Upthegrove, Malcolm J. Price, Megan Pritchard, Joht Singh Chandan, Sophie Legge, James H. MacCabe |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2022-06-01
|
Series: | Therapeutic Advances in Psychopharmacology |
Online Access: | https://doi.org/10.1177/20451253221103353 |
Similar Items
-
The lived experience of clozapine discontinuation in patients and carers following suspected clozapine-induced neutropenia
by: Ebenezer Oloyede, et al.
Published: (2023-06-01) -
Sudden-onset catatonia following Clozapine withdrawal: a case report
by: Koychev, I, et al.
Published: (2016) -
Management of clozapine treatment during the COVID-19 pandemic
by: Siobhan Gee, et al.
Published: (2020-05-01) -
Distinctive pattern of neutrophil count change in clozapine-associated, life-threatening agranulocytosis
by: David Taylor, et al.
Published: (2022-03-01) -
Clozapine in severe psychotic disorders: Balancing safety with efficacy
by: R. Almeida Leite, et al.
Published: (2021-04-01)